Skip to main content
Article
Dendrimer-Based RNA Interference Delivery for Cancer Therapy
ACS Symposium Series
  • Leyuan Xu
  • W. Andrew Yeudall
  • Hu Yang, Missouri University of Science and Technology
Abstract

RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.

Department(s)
Chemical and Biochemical Engineering
Keywords and Phrases
  • Dendrimers,
  • Diseases,
  • Medical applications,
  • RNA, Cancer therapy,
  • RNA interference, Functional polymers
International Standard Book Number (ISBN)
978-084122798-9
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2013 American Chemical Society (ACS), All rights reserved.
Publication Date
7-8-2013
Publication Date
08 Jul 2013
Citation Information
Leyuan Xu, W. Andrew Yeudall and Hu Yang. "Dendrimer-Based RNA Interference Delivery for Cancer Therapy" ACS Symposium Series Vol. 1135 (2013) p. 197 - 213 ISSN: 0097-6156; 1947-5918
Available at: http://works.bepress.com/hu-yang/9/